| For: | Uygun Ilikhan S, Bilici M, Sahin H, Demir Akca AS, Can M, Oz II, Guven B, Buyukuysal MC, Ustundag Y. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma. World J Gastroenterol 2015; 21(22): 6999-7007 [PMID: 26078578 DOI: 10.3748/wjg.v21.i22.6999] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i22/6999.htm |
| Number | Citing Articles |
| 1 |
Jianfa Li, Yincong Chen, Zhicong Chen, Anbang He, Haibiao Xie, Qiaoxiao Zhang, Zhiming Cai, Yuchen Liu, Weiren Huang. SPRY4-IT1: A novel oncogenic long non-coding RNA in human cancers. Tumor Biology 2017; 39(6) doi: 10.1177/1010428317711406
|
| 2 |
Aonan Zhu, Xiaoyu Zhao, Mingyu Cheng, Lei Chen, Yaxin Wang, Xiaolong Zhang, Yongjun Zhang, Xuefeng Zhang. Nanohoneycomb Surface-Enhanced Raman Spectroscopy-Active Chip for the Determination of Biomarkers of Hepatocellular Carcinoma. ACS Applied Materials & Interfaces 2019; 11(47) doi: 10.1021/acsami.9b16288
|
| 3 |
Na Yu. GSEMT: A Gene Set Enrichment Analysis Method Based on Mantel Test. Journal of Physics: Conference Series 2021; 1828(1) doi: 10.1088/1742-6596/1828/1/012048
|
| 4 |
Wei Jing, Shanshan Gao, Man Zhu, Ping Luo, Xuan Jing, Hongyan Chai, Jiancheng Tu. Potential diagnostic value of lncRNA SPRY4-IT1 in hepatocellular carcinoma. Oncology Reports 2016; 36(2) doi: 10.3892/or.2016.4859
|
| 5 |
Fuyou Zhang, Jianfa Li, Huizhong Xiao, Yifan Zou, Yuchen Liu, Weiren Huang. AFAP1‐AS1: A novel oncogenic long non‐coding RNA in human cancers. Cell Proliferation 2018; 51(1) doi: 10.1111/cpr.12397
|
| 6 |
子琦 王. Ginsenoside Rh2: A Potential Therapeutic Strategy for Liver Cancer. Advances in Clinical Medicine 2026; 16(01) doi: 10.12677/acm.2026.161285
|
| 7 |
Eva Juárez-Hernández, Daniel Motola-Kuba, Norberto Carlos Chávez-Tapia, Misael Uribe, Varenka Barbero Becerra. Biomarkers in hepatocellular carcinoma: an overview. Expert Review of Gastroenterology & Hepatology 2017; 11(6) doi: 10.1080/17474124.2017.1311785
|
| 8 |
Manyu Li, Jing Sun, Yan Wang, Jun Ma, Xiaotian Hao, Yan Liu, Cheng Zhou, Haiwei Zhou. Construction of a hepatocellular carcinoma high-risk population rating scale and independent predictors' assessment. The American Journal of the Medical Sciences 2024; 367(3) doi: 10.1016/j.amjms.2023.11.016
|
| 9 |
S.S. Haque, Ravi Bhushan Raman, Mehboobus Salam. Liver Cancer - Genesis, Progression and Metastasis. 2023; doi: 10.5772/intechopen.105856
|
| 10 |
Li-Na Ma, Yan Ma, Xia Luo, Zi-min Ma, Li-Na Ma, Xiang-Chun Ding. AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-62323-5
|
| 11 |
Ting Song, Lili Wang, Bin Su, Weiping Zeng, Taiyi Jiang, Tong Zhang, Guizhen Sun, Hao Wu. Diagnostic value of alpha-fetoprotein, Lens culinaris agglutinin-reactive alpha-fetoprotein, and des-gamma-carboxyprothrombin in hepatitis B virus-related hepatocellular carcinoma. Journal of International Medical Research 2020; 48(3) doi: 10.1177/0300060519889270
|
| 12 |
Ping Luo, Wei Jing, Man Zhu, Nan-Di Li, Hu Zhou, Ming-Xia Yu, Chun-Zi Liang, Jian-Cheng Tu. Decreased expression of LncRNA SRA1 in hepatocellular carcinoma and its clinical significance. Cancer Biomarkers 2017; 18(3) doi: 10.3233/CBM-160305
|
| 13 |
Ting Wang, Kun-He Zhang. New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01316
|
| 14 |
佳骏 芦. Application of Serum Biomarkers in Early Diagnosis and Prognosis of Hepatocellular Carcinoma. Advances in Clinical Medicine 2022; 12(06) doi: 10.12677/ACM.2022.126789
|
| 15 |
Johanna K. DiStefano, Bethany Davis. Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma. Cancers 2019; 11(4) doi: 10.3390/cancers11040486
|
| 16 |
Ping Luo, Sanyun Wu, Yalan Yu, Xinliang Ming, Shuo Li, Xuelan Zuo, Jiancheng Tu. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage. Pathology & Oncology Research 2020; 26(2) doi: 10.1007/s12253-019-00585-5
|
| 17 |
Faruk Kucukdurmaz, Erkan Efe, Ahmet Çelik, Hasan Dagli, Metin Kılınc, Sefa Resim. Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer. BMC Urology 2017; 17(1) doi: 10.1186/s12894-017-0303-6
|
| 18 |
Harish Gopalakrishna, Bilal Asif, Anjali Rai, Hari S. Conjeevaram, Maria Mironova, David E. Kleiner, Alexandra F. Freeman, Theo Heller. Chronic Liver Disease in Patients with Prolidase Deficiency: A Case Series. Case Reports in Gastroenterology 2024; 18(1) doi: 10.1159/000536117
|
| 19 |
Wei Li, Qiang Fu, Wenling Man, Huanqing Guo, Po Yang. LncRNA OR3A4 participates in the angiogenesis of hepatocellular carcinoma through modulating AGGF1/akt/mTOR pathway. European Journal of Pharmacology 2019; 849 doi: 10.1016/j.ejphar.2019.01.049
|
| 20 |
Ningbin Luo, Wenzhu Li, Jisheng Xie, Danhui Fu, Lidong Liu, Xiangyang Huang, Danke Su, Guanqiao Jin. Preoperative normalized iodine concentration derived from spectral CT is correlated with early recurrence of hepatocellular carcinoma after curative resection. European Radiology 2021; 31(4) doi: 10.1007/s00330-020-07330-6
|
| 21 |
Johanna K. DiStefano, Glenn S. Gerhard. Long Noncoding RNAs and Human Liver Disease. Annual Review of Pathology: Mechanisms of Disease 2022; 17(1) doi: 10.1146/annurev-pathol-042320-115255
|
| 22 |
Isa Ozbay, Muhammet Fatih Topuz, Fatih Oghan, Havva Kocak, Cuneyt Kucur. Serum prolidase, malondialdehyde and catalase levels for the evaluation of oxidative stress in patients with peripheral vertigo. European Archives of Oto-Rhino-Laryngology 2021; 278(10) doi: 10.1007/s00405-020-06466-x
|
| 23 |
Huizhong Xiao, Fuyou Zhang, Yifan Zou, Jianfa Li, Yuchen Liu, Weiren Huang. The Function and Mechanism of Long Non-coding RNA-ATB in Cancers. Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.00321
|
| 24 |
Yameng Zhang, Yufei Gao, Youhe Gao. Early changes in the urine proteome in a rat liver tumour model. PeerJ 2020; 8 doi: 10.7717/peerj.8462
|
| 25 |
Mehmet Kaba, Sinan Kılıç, Halit Demir. Evaluation of antioxidant enzyme levels, oxidative stress markers and serum prolidase activity in testicular cancer. Urologia Journal 2024; 91(4) doi: 10.1177/03915603241249232
|
| 26 |
Zhuo Han, Keming Li, Jinyu Wu, Keyan Wang, Cuipeng Qiu, Hua Ye, Chi Cui, Chunhua Song, Kaijuan Wang, Jianxiang Shi, Peng Wang, Jianying Zhang. Diagnostic Value of Rna for Hepatocellular Carcinoma: A Network Meta-Analysis. Biomarkers in Medicine 2021; 15(18) doi: 10.2217/bmm-2021-0327
|
| 27 |
Johanna K. DiStefano. Long noncoding RNAs in the initiation, progression, and metastasis of hepatocellular carcinoma. Non-coding RNA Research 2017; 2(3-4) doi: 10.1016/j.ncrna.2017.11.001
|
| 28 |
Qing-Qin Hao, Guang-Yi Chen, Jun-Hua Zhang, Jia-He Sheng, Yun Gao. Diagnostic value of long noncoding RNAs for hepatocellular carcinoma. Medicine 2017; 96(28) doi: 10.1097/MD.0000000000007496
|
| 29 |
Zhen Lu, A-Man Xu, Zhi-Jian Wei, En-Dong Song, Li-Xiang Zhang, Zheng-Hui Ye, Pan-Quan Luo. Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model. World Journal of Clinical Cases 2022; 10(36): 13250-13263 doi: 10.12998/wjcc.v10.i36.13250
|
| 30 |
Honglei Feng, Jiawei Xiao, Ze Li, Qian Wei, Bole Li, Li Ren. The prognostic value of protein induced by vitamin K absence or antagonist-II in hepatocellular carcinoma patients undergoing surgical resection. European Journal of Gastroenterology & Hepatology 2026; 38(4) doi: 10.1097/MEG.0000000000003130
|
| 31 |
Qingqin Hao, Yadi Han, Wei Xia, Qinghui Wang, Huizhong Qian. Systematic Review and Meta-Analysis of the Utility of Circular RNAs as Biomarkers of Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2019; 2019 doi: 10.1155/2019/1684039
|